# Filing Detail

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001493152-21-008140
Filing Date
2021-04-07
Accepted
2021-04-07 07:35:46
Documents
65

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | forms-1a.htm | S-1/A | 1960408
2 |  | ex23-1.htm | EX-23.1 | 4095
3 |  | s-1_001.jpg | GRAPHIC | 7111
4 |  | img_005.jpg | GRAPHIC | 122365
5 |  | img_006.jpg | GRAPHIC | 38429
6 |  | img_003.jpg | GRAPHIC | 20507
7 |  | img_004.jpg | GRAPHIC | 17302
| Complete submission text file | 0001493152-21-008140.txt |  | 5350992

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL INSTANCE FILE | ptix-20201231.xml | EX-101.INS | 600760
9 | XBRL SCHEMA FILE | ptix-20201231.xsd | EX-101.SCH | 44035
10 | XBRL CALCULATION FILE | ptix-20201231_cal.xml | EX-101.CAL | 52916
11 | XBRL DEFINITION FILE | ptix-20201231_def.xml | EX-101.DEF | 201816
12 | XBRL LABEL FILE | ptix-20201231_lab.xml | EX-101.LAB | 346153
13 | XBRL PRESENTATION FILE | ptix-20201231_pre.xml | EX-101.PRE | 279763

Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-253006 | Film No.: 21810696
SIC: 7389 Services-Business Services, NEC